Abbott Laboratories Total Assets 2006-2018 | ABT

Abbott Laboratories total assets from 2006 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Abbott Laboratories total assets for the quarter ending December 31, 2018 were $67.173B, a 11.9% decline year-over-year.
  • Abbott Laboratories total assets for 2018 were $67.173B, a 11.9% decline from 2017.
  • Abbott Laboratories total assets for 2017 were $76.25B, a 44.78% increase from 2016.
  • Abbott Laboratories total assets for 2016 were $52.666B, a 27.68% increase from 2015.
Abbott Laboratories Annual Total Assets
(Millions of US $)
2018 $67,173
2017 $76,250
2016 $52,666
2015 $41,247
2014 $41,207
2013 $42,953
2012 $67,235
2011 $60,277
2010 $60,574
2009 $52,582
2008 $42,419
2007 $39,714
2006 $36,178
2005 $29,141
Abbott Laboratories Quarterly Total Assets
(Millions of US $)
Q4 2018 $67,173
Q3 2018 $71,637
Q2 2018 $68,415
Q1 2018 $70,908
Q4 2017 $76,250
Q3 2017 $72,248
Q2 2017 $71,151
Q1 2017 $70,887
Q4 2016 $52,666
Q3 2016 $39,497
Q2 2016 $39,831
Q1 2016 $39,637
Q4 2015 $41,247
Q3 2015 $41,725
Q2 2015 $44,125
Q1 2015 $43,095
Q4 2014 $41,207
Q3 2014 $42,514
Q2 2014 $41,475
Q1 2014 $41,662
Q4 2013 $42,953
Q3 2013 $44,132
Q2 2013 $42,903
Q1 2013 $42,687
Q4 2012 $67,235
Q3 2012 $63,258
Q2 2012 $61,860
Q1 2012 $62,416
Q4 2011 $60,277
Q3 2011 $59,628
Q2 2011 $62,004
Q1 2011 $61,651
Q4 2010 $60,574
Q3 2010 $57,374
Q2 2010 $53,381
Q1 2010 $53,359
Q4 2009 $52,582
Q3 2009 $49,847
Q2 2009 $47,630
Q1 2009 $45,438
Q4 2008 $42,419
Q3 2008 $41,753
Q2 2008 $44,074
Q1 2008 $41,178
Q4 2007 $39,714
Q3 2007 $37,622
Q2 2007 $37,153
Q1 2007 $36,286
Q4 2006 $36,178
Q3 2006 $33,300
Q2 2006 $34,061
Q1 2006 $28,532
Q4 2005 $29,141
Q3 2005 $28,831
Q2 2005 $27,817
Q1 2005 $28,857
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $136.952B $30.578B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $121.227B 17.72
Stryker (SYK) United States $72.547B 26.60
Boston Scientific (BSX) United States $51.696B 25.20
Baxter (BAX) United States $39.588B 25.33
Zimmer Biomet Holdings (ZBH) United States $25.898B 16.58
Smith & Nephew SNATS (SNN) United Kingdom $17.446B 0.00
Canopy Growth (CGC) Canada $14.852B 0.00
ResMed (RMD) United States $14.350B 27.21
Bio-Rad Laboratories (BIO) United States $9.156B 52.24
Aurora Cannabis (ACB) Canada $9.141B 64.50
Hill-Rom Holdings (HRC) United States $6.962B 21.53
Perrigo (PRGO) Ireland $6.420B 10.41
Insulet (PODD) United States $5.800B 1956.80
GW Pharmaceuticals (GWPH) United Kingdom $5.092B 0.00
ICU Medical (ICUI) United States $4.698B 29.24
Haemonetics (HAE) United States $4.311B 38.24
Hutchison China MediTech (HCM) China $3.810B 0.00
Agios Pharmaceuticals (AGIO) United States $3.637B 0.00
Neogen (NEOG) United States $3.108B 47.74
NuVasive (NUVA) United States $2.892B 25.23
Quidel (QDEL) United States $2.514B 22.68
Aphria (APHA) $2.385B 105.89
National Vision Holdings (EYE) United States $2.274B 44.72
Cardiovascular Systems (CSII) United States $1.346B 966.50
Phibro Animal Health (PAHC) United States $1.283B 18.45
VAREX IMAGING (VREX) United States $1.275B 24.96
AtriCure (ATRC) United States $1.081B 0.00
MacroGenics (MGNX) United States $0.926B 0.00
Lantheus Holdings (LNTH) United States $0.911B 24.60
Cerus (CERS) United States $0.844B 0.00
PetIQ (PETQ) United States $0.831B 23.77
Omeros (OMER) United States $0.828B 0.00
NanoString Technologies (NSTG) United States $0.729B 0.00
Meridian Bioscience (VIVO) United States $0.715B 21.30
OraSure Technologies (OSUR) United States $0.664B 29.11
Eagle Pharmaceuticals (EGRX) United States $0.657B 22.35
Evolus (EOLS) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.601B 0.00
LeMaitre Vascular (LMAT) United States $0.596B 28.35
Surmodics (SRDX) United States $0.563B 81.90
Quanterix (QTRX) United States $0.518B 0.00
BioLife Solutions (BLFS) United States $0.364B 150.23
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.331B 0.00
Insys Therapeutics (INSY) United States $0.328B 0.00
Utah Medical Products (UTMD) United States $0.300B 19.49
Owens & Minor (OMI) United States $0.271B 3.76
Bovie Medical (APYX) United States $0.260B 0.00
Cytosorbents (CTSO) United States $0.241B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.238B 0.00
Zynex (ZYXI) United States $0.145B 15.52
Fonar (FONR) United States $0.137B 7.33
Surface Oncology (SURF) United States $0.116B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
United-Guardian (UG) United States $0.087B 19.84
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 17.14
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Senestech (SNES) United States $0.029B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.29